Chemo Na Ve Patients Websites
First-line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer
Portrazza in combination with gemcitabine and cisplatin, is the first approved biologic for the treatment of patients who are chemo-naive for their metastatic non-small cell lung cancer.
Not Applicable
$
8.95
